Drugs / PRO-513
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00330850 | May → Dec 2006 | hyperacusis, migraine disorder | ProEthic Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-513 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00330850 ↗ |